title: Evaluating Free Energies of Binding and Conservation of Crystallographic Waters Using SZMAP.
abstract: The SZMAP method computes binding free energies and the corresponding thermodynamic components for water molecules in the binding site of a protein structure [ SZMAP, 1.0.0 ; OpenEye Scientific Software Inc. : Santa Fe, NM, USA , 2011 ]. In this work, the ability of SZMAP to predict water structure and thermodynamic stability is examined for the X-ray crystal structures of a series of protein-ligand complexes. SZMAP results correlate with higher-level replica exchange thermodynamic integration double decoupling calculations of the absolute free energy of bound waters in the test set complexes. In addition, SZMAP calculations show good agreement with experimental data in terms of water conservation (across multiple crystal structures) and B-factors over a subset of the test set. In particular, the SZMAP neutral entropy difference term calculated at crystallographic water positions within each of the complex structures correlates well with whether that crystallographic water is conserved or displaceable. Furthermore, the calculated entropy of the water probe relative to the continuum shows a significant degree of correlation with the B-factors associated with the oxygen atoms of the water molecules. Taken together, these results indicate that SZMAP is capable of quantitatively predicting water positions and their energetics and is potentially a useful tool for determining which waters to attempt to displace, maintain, or build in through water-mediated interactions when evolving a lead series during a drug discovery program.
authors.affiliation: Oncology and Infection Innovative Medicines Units, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.
authors.forename: Alexander S
authors.initials: AS
authors.lastname: Bayden
authors.affiliation: Oncology and Infection Innovative Medicines Units, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.
authors.forename: Demetri T
authors.initials: DT
authors.lastname: Moustakas
authors.affiliation: Oncology and Infection Innovative Medicines Units, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.
authors.forename: Diane
authors.initials: D
authors.lastname: Joseph-McCarthy
authors.affiliation: Oncology and Infection Innovative Medicines Units, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.
authors.forename: Michelle L
authors.initials: ML
authors.lastname: Lamb
mesh_terms: D001426:Bacterial Proteins / Q000737:chemistry; D001665:Binding Sites; D002352:Carrier Proteins / Q000737:chemistry; D018360:Crystallography, X-Ray; D030562:Databases, Protein; D016333:HIV Protease / Q000737:chemistry; D015497:HIV-1 / Q000737:chemistry; D008024:Ligands; D008074:Lipoproteins / Q000737:chemistry; D008958:Models, Molecular; D011485:Protein Binding; D011506:Proteins / Q000737:chemistry*; D019779:Salmonella enterica / Q000737:chemistry; D012984:Software; D013816:Thermodynamics; D014867:Water / Q000737:chemistry*
chemical_list: D001426:Bacterial Proteins; D002352:Carrier Proteins; D008024:Ligands; D008074:Lipoproteins; D011506:Proteins; C046506:oligopeptide-binding protein, bacteria; D014867:Water; D016333:HIV Protease; C514803:p16 protease, Human immunodeficiency virus 1